Immunodiagnostic Systems Holdings Plc (LON: IDH) has released its interim results for the six-month period ended 30 September 2020.

  • The unaudited Group revenues for the reported period were 27 per cent lower than the same period last year on both at constant FX rates and reported basis, at £13.7 million.
  • The Revenues in the first quarter were £5.7 million only but had increased considerably to £8.0 million in the second quarter.
  • Adjusted EBITDA, decreased from a profit of £2.9 million in H1 FY20 to a loss of £0.8 million in H1 FY21.

 

 


Disclaimer
The website https://kalkinemedia.com/uk is a service of Kalkine Media Ltd, Company Number 12643132. The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK